tiprankstipranks
Advertisement
Advertisement

VTGN Stock Latest News

VistaGen reports Phase 2 fasedienol trial topline results
Company AnnouncementsVistaGen reports Phase 2 fasedienol trial topline results
17d ago
8K
VTGN
Vistagen announces topline results from fasedienol repeat dose study
PremiumThe Fly
Vistagen announces topline results from fasedienol repeat dose study
18d ago
VTGN
VistaGen Granted Nasdaq Extension to Regain Bid Compliance
PremiumCompany Announcements
VistaGen Granted Nasdaq Extension to Regain Bid Compliance
18d ago
8K
VTGN
SRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics
PremiumTipRanks Newswire
SRX Global (NYSE American: SRXH) Acquires Stake in Vistagen Therapeutics
19d ago
SRXH
VTGN
SRX Global acquires stake in Vistagen
PremiumThe Fly
SRX Global acquires stake in Vistagen
20d ago
SRXH
VTGN
Vistagen Therapeutics Inc. (VTGN) Q1 Earnings Cheat Sheet
PremiumPre-EarningsVistagen Therapeutics Inc. (VTGN) Q1 Earnings Cheat Sheet
20d ago
VTGN
VistaGen Therapeutics Appoints Douglas Williamson to Board
Premium
Company Announcements
VistaGen Therapeutics Appoints Douglas Williamson to Board
24d ago
8K
VTGN
VistaGen pivots fasedienol toward long-term anxiety treatment
Premium
Company Announcements
VistaGen pivots fasedienol toward long-term anxiety treatment
2M ago
8K
VTGN
Vistagen announces fasedienol did not achieve primary endpoint
PremiumThe Fly
Vistagen announces fasedienol did not achieve primary endpoint
2M ago
VTGN
Vistagen Therapeutics’ 2026 Workforce Cuts Raise Execution Risks and Threaten Long-Term Growth
PremiumCompany Announcements
Vistagen Therapeutics’ 2026 Workforce Cuts Raise Execution Risks and Threaten Long-Term Growth
2M ago
VTGN
VistaGen Reaches Key Safety Milestone for Fasedienol Program
PremiumCompany Announcements
VistaGen Reaches Key Safety Milestone for Fasedienol Program
3M ago
8K
VTGN
Vistagen announces fasedienol achieves minimum patient exposures
PremiumThe Fly
Vistagen announces fasedienol achieves minimum patient exposures
3M ago
VTGN
VistaGen Appoints New Chief Medical Officer to Advance Pipeline
PremiumCompany AnnouncementsVistaGen Appoints New Chief Medical Officer to Advance Pipeline
3M ago
8K
VTGN
Vistagen appoints Angelov as Chief Medical Officer
Premium
The Fly
Vistagen appoints Angelov as Chief Medical Officer
3M ago
VTGN
VistaGen Reports Positive Long-Term Data for Fasedienol
Premium
Company Announcements
VistaGen Reports Positive Long-Term Data for Fasedienol
3M ago
8K
VTGN
Vistagen reports preliminary positive data on ongoing PALISADE-3 study
PremiumThe Fly
Vistagen reports preliminary positive data on ongoing PALISADE-3 study
3M ago
VTGN
VistaGen Completes Phase 3 PALISADE-4 Trial Milestone
PremiumCompany Announcements
VistaGen Completes Phase 3 PALISADE-4 Trial Milestone
4M ago
8K
VTGN
Vistagen announces completion of last patient visit in PALISADE-4 study
PremiumThe Fly
Vistagen announces completion of last patient visit in PALISADE-4 study
4M ago
VTGN
VistaGen Advances Refisolone Nasal Spray in U.S. Phase 2
PremiumCompany Announcements
VistaGen Advances Refisolone Nasal Spray in U.S. Phase 2
4M ago
8K
VTGN
AbCellera target is profile more attractive than Vistagen, says JonesResearch
PremiumThe FlyAbCellera target is profile more attractive than Vistagen, says JonesResearch
4M ago
ABCL
VTGN
Vistagen receives FDA ‘Study May Proceed’ letter under refisolone IND filing
Premium
The Fly
Vistagen receives FDA ‘Study May Proceed’ letter under refisolone IND filing
4M ago
VTGN
VistaGen Therapeutics Grants Broad Employee Retention Stock Options
Premium
Company Announcements
VistaGen Therapeutics Grants Broad Employee Retention Stock Options
4M ago
8K
VTGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >